NEW YORK, Feb. 04, 2026 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds agilon health, inc. (“agilon” or the “Company”) (NYSE:AGL) investors of the March 2, 2026 lead plaintiff deadline to seek lead plaintiff appointment in the class action filed on behalf of investors who acquired agilon securities between February 26, 2025 through August 4, 2025 (“the Class Period”). Courts do not consider applications filed after the lead plaintiff deadline. The lead plaintiff oversees the litigation on b ...

Core Viewpoint - A lawsuit has been filed against agilon health, inc. (NYSE: AGL) by an investor alleging violations of Federal Securities Laws, with a deadline for affected investors to take action by March 2, 2026 [1][2][3]. Group 1: Lawsuit Details - The lawsuit claims that agilon health, inc. made false and misleading statements regarding its financial guidance for 2025, which the defendants allegedly knew was unattainable due to industry challenges [3]. - The plaintiff asserts that the defendants overstated the positive financial impact of strategic actions taken to mitigate risks, leading to materially false representations about the company's business and prospects [3]. Group 2: Investor Information - Investors who purchased shares of agilon health, inc. between February 26, 2025, and August 4, 2025, and invested over $100,000 are encouraged to contact the Shareholders Foundation for assistance [2][4]. - The Shareholders Foundation provides legal monitoring and settlement claim filing services related to shareholder issues, but it is not a law firm [4].

LOS ANGELES, Feb. 02, 2026 (GLOBE NEWSWIRE) -- Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming March 2, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired agilon health, inc. (“agilon” or the “Company”) (NYSE: AGL) securities between February 26, 2025 and August 4, 2025, inclusive (the “Class Period”). IF YOU SUFFERED A LOSS ON YOUR AGILON INVESTMENTS, CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS T ...

Core Viewpoint - Rosen Law Firm is reminding investors who purchased agilon health, inc. securities between February 26, 2025, and August 4, 2025, of the March 2, 2026, deadline to become lead plaintiffs in a securities class action lawsuit [1]. Group 1: Class Action Details - Investors who purchased agilon securities during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties must move the Court by March 2, 2026, to serve as lead plaintiff, representing other class members [3]. - The lawsuit alleges that defendants made false or misleading statements and failed to disclose critical information regarding agilon's financial guidance and business operations, leading to investor damages when the truth was revealed [5]. Group 2: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions, highlighting its own achievements, including the largest securities class action settlement against a Chinese company [4]. - The firm has been ranked No. 1 for securities class action settlements in 2017 and has consistently ranked in the top 4 since 2013, recovering hundreds of millions of dollars for investors, including over $438 million in 2019 alone [4].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased securities of Agilon Health, Inc. during the specified Class Period of the upcoming lead plaintiff deadline for a securities class action lawsuit [1] Group 1: Class Action Details - Investors who purchased Agilon securities between February 26, 2025, and August 4, 2025, may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2] - A class action lawsuit has already been filed, and those wishing to serve as lead plaintiff must act by March 2, 2026 [3] - Investors can join the class action by visiting the provided link or contacting the law firm directly for more information [6] Group 2: Law Firm Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company and being ranked No. 1 for settlements in 2017 [4] - The firm has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone [4] - Founding partner Laurence Rosen was recognized as a Titan of Plaintiffs' Bar by Law360 in 2020, highlighting the firm's expertise and reputation in the field [4] Group 3: Case Allegations - The lawsuit alleges that Agilon's defendants made false or misleading statements and failed to disclose critical information regarding their 2025 guidance and the financial impact of strategic actions taken [5] - It is claimed that the defendants were aware of material industry headwinds that would prevent achieving their guidance, leading to materially false statements about Agilon's business and prospects [5] - The lawsuit asserts that when the true information became public, investors suffered damages as a result [5]

NEW YORK, Jan. 29, 2026 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in agilon health, inc. ("agilon health, inc." or the "Company") (NYSE: AGL) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of agilon health, inc. investors who were adversely affected by alleged securities fraud between February 26, 2025 and August 4, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/ag ...

Core Viewpoint - The Gross Law Firm is notifying shareholders of Agilon Health, Inc. (NYSE: AGL) about a class action lawsuit due to alleged misleading statements and guidance issued by the company during a specified class period [1][3]. Group 1: Allegations - The complaint alleges that during the class period from February 26, 2025, to August 4, 2025, Agilon Health's defendants issued materially false and misleading statements [3]. - It is claimed that the defendants recklessly provided guidance for 2025 that they knew or should have known was unattainable due to significant industry challenges [3]. - The complaint also states that the defendants overstated the immediate positive financial impact from strategic actions taken to mitigate risks, leading to materially false and misleading statements regarding Agilon's business and prospects [3]. Group 2: Class Action Details - Shareholders who purchased AGL shares during the class period are encouraged to register for the class action, with a deadline for lead plaintiff appointment set for March 2, 2026 [4]. - Once registered, shareholders will be enrolled in a portfolio monitoring system to receive updates on the case's progress [4]. - Participation in the case incurs no cost or obligation for the shareholders [4]. Group 3: Law Firm Background - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights against deceit and illegal business practices [5]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements or omissions that inflated stock prices [5].

NEW YORK--(BUSINESS WIRE)--Kirby McInerney LLP reminds agilon health, inc. ("agilon†or the "Company†) (NYSE:AGL) investors of the March 2, 2026 deadline to seek the role of lead plaintiff in a pending federal securities class action. Courts do not consider applications filed after this deadline. The lead plaintiff oversees the litigation on behalf of the class and may influence key decisions, including litigation strategy and settlement. Courts regularly appoint individual investors as lead plaintiffs, no ...

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Agilon (AGL) To Contact Him Directly To Discuss Their Options If you purchased or acquired Agilon securities between February 26, 2025 and August 4, 2025 and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Melissa Forunato directly at (212) 355-4648. Click here to participate in the action. NEW YORK, Jan. 27, 2026 (GLOBE NEWSWIRE) -- What’s Happening? Braga ...

SAN DIEGO, Jan. 27, 2026 /PRNewswire/ -- Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired agilon health, inc. (NYSE: AGL) securities between February 26, 2025 and August 4, 2025. Agilon describes itself as the "trusted partner empowering physicians to transform health care in our communities." For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. What are the allegations? Robbin ...